Otsuka Holdings
4578.T
#741
Rank
โ‚น2.823 T
Marketcap
โ‚น5,346
Share price
1.03%
Change (1 day)
9.45%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Revenue for Otsuka Holdings (4578.T)

Revenue in 2023: โ‚น1.182 Trillion

According to Otsuka Holdings 's latest financial reports the company's current revenue (TTM ) is โ‚น1.302 Trillion. In 2023 the company made a revenue of โ‚น1.182 Trillion an increase over the revenue in the year 2022 that were of โ‚น1.079 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Otsuka Holdings from 2010 to 2023

Annual revenue

Year Revenue Change
2023โ‚น1.182 T9.51%
2022โ‚น1.079 T8.55%
2021โ‚น994.56 B1.27%
2020โ‚น982.04 B7.52%
2019โ‚น913.39 B11.55%
2018โ‚น818.79 B16.07%
2017โ‚น705.40 B-5.27%
2016โ‚น744.66 B-6.44%
2015โ‚น795.95 B
2013โ‚น873.08 B11.45%
2012โ‚น783.36 B3.6%
2011โ‚น756.14 B31.99%
2010โ‚น572.86 B